Clover Health Investments (CLOV) shares were up 4.9% in recent Friday trading after the company announced that its preferred provider organizations Medicare Advantage plans were rated 4 stars for 2025 by the Centers for Medicare and Medicaid Services.
The company said this will affect payment year 2026, adding that over 95% of its Medicare Advantage membership is served through its PPO plans.
CMS also increased Clover's health maintenance organization Medicare Advantage plans rating to 3.5 stars, the company added.
Clover Health said its higher overall rating reflects its performance across several measures, including its 4.94 stars out of 5 stars on healthcare effectiveness data and information set.
Price: 4.15, Change: +0.19, Percent Change: +4.94
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。